Vera Therapeutics, Inc.
VERA · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Fordyce Marshall: Form 4
Insider disclosure · Filed · Report period 15 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- VERA · 92337R101 - Class A common stock, $0.001 par value per share
Company details and SEC sources
CIK 0001831828 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- VERA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2000 Sierra Point Parkway, Suite 1200, Brisbane, CA, 94005
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields